Darrell S. Rigel

Q: What Schools Are Affiliated With Darrell S. Rigel

Darrell S. Rigel is affiliated with the following schools: Icahn School of Medicine at Mount Sinai, New York University

Darrell S. Rigel's AcademicInfluence.com Rankings

Darrell S. Rigel

Medical

#2612

World Rank

#3043

Historical Rank

Dermatology

#53

World Rank

#70

Historical Rank

medical Degrees

Darrell S. Rigel

Philosophy

#7512

World Rank

#10735

Historical Rank

Logic

#4563

World Rank

#5873

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Darrell S. Rigel's Degrees

Doctorate Medicine New York University
PhD Immunology New York University

Why Is Darrell S. Rigel Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Darrell S. Rigel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Early detection of malignant melanoma: The role of physician examination and self‐examination of the skin (1985) (797)
Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. (2004) (605)
Malignant melanoma: Prevention, early detection, and treatment in the 21st century (2000) (445)
Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma (1992) (435)
The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs (2010) (411)
The incidence of malignant melanoma in the United States: issues as we approach the 21st century. (1996) (354)
Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. (2008) (275)
Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. (1997) (274)
Prognostic significance of hypopigmentation in malignant melanoma. (1987) (229)
Malignant melanoma in the 1990s: The continued importance of earlydetection and the role of physician examination and self‐examination of theskin (1991) (193)
Selection criteria for genetic assessment of patients with familial melanoma. (2009) (168)
Prognostic Factors for Melanoma Patients with Lesions 0.76–1.69 mm in Thickness An Appraisal of “Thin” Level IV Lesions (1982) (167)
Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. (1996) (160)
Melanoma awareness and self-examination practices: results of a United States survey. (1996) (157)
Summertime sun protection used by adults for their children. (2000) (156)
ABCDE--an evolving concept in the early detection of melanoma. (2005) (156)
Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis (1982) (155)
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles. (2010) (155)
Risk factors for the development of malignant melanoma--I: Review of case-control studies. (1988) (151)
“Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness (1984) (134)
The use of photodynamic therapy in dermatology: results of a consensus conference. (2006) (131)
Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. (1996) (129)
Actinic Keratosis, Basal Cell Carcinoma and Squamous Cell Carcinoma (2012) (126)
Local and In‐Transit Metastases Following Definitive Excision for Primary Cutaneous Malignant Melanoma (1983) (115)
The rate of malignant melanoma in the United States: are we making an impact? (1987) (115)
The rising incidence and mortality rate of malignant melanoma. (1982) (111)
Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications (1995) (109)
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. (1982) (108)
Analysis of Trends in US Melanoma Incidence and Mortality (2017) (108)
Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. (1995) (107)
Importance of complete cutaneous examination for the detection of malignant melanoma. (1986) (107)
Thickness of malignant melanoma: global analysis of related factors. (1987) (96)
What promotes skin self-examination? (1998) (95)
Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005. (2007) (95)
Prevalence of congenital-nevus-like nevi, nevi spili, and café au lait spots. (1985) (94)
Predicting ten‐year survival of patients with primary cutaneous melanoma (1997) (91)
Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). (2004) (90)
Dysplastic nevi. Markers for increased risk for melanoma. (1989) (89)
Effects of altitude and latitude on ambient UVB radiation. (1999) (89)
Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study. (1994) (89)
The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas. (2008) (86)
The importance of early diagnosis and treatment of actinic keratosis. (2013) (83)
Sunlight, tanning booths, and vitamin D. (2005) (82)
Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome. (1991) (80)
Adverse effects of ultraviolet radiation from the use of indoor tanning equipment: time to ban the tan. (2011) (80)
Epidemiology of melanoma. (2010) (80)
Risk factors for local recurrence of primary cutaneous squamous cell carcinomas. Treatment by microscopically controlled excision. (1982) (79)
Regression in malignant melanoma. (1983) (74)
Effect of anatomical location on prognosis in patients with clinical stage I melanoma. (1983) (72)
Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi. (1983) (71)
Malignant melanoma: Perspectives on incidence and its effects on awareness, diagnosis, and treatment (1996) (70)
Malignant melanoma: incidence issues and their effect on diagnosis and treatment in the 1990s. (1997) (68)
Malignant acanthosis nigricans: a review. (1980) (66)
Basal-cell carcinomas on covered or unusual sites of the body. (1981) (66)
High-SPF sunscreens (SPF ≥ 70) may provide ultraviolet protection above minimal recommended levels by adequately compensating for lower sunscreen user application amounts. (2012) (65)
Analysis of Trends in Geographic Distribution and Density of US Dermatologists (2017) (64)
Adverse effects of ultraviolet radiation from the use of indoor tanning equipment: time to ban the tan. (2011) (62)
Atypical mole syndrome. (1990) (62)
Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi (1990) (61)
Prognostic index for malignant melanoma (1987) (61)
Sun Protection Attitudes and Behaviors of Solid‐Organ Transplant Recipients (2004) (60)
Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery. (2008) (60)
Cutaneous melanoma--past, present, and future. (2004) (59)
Ultraviolet radiation in alpine skiing: magnitude of exposure and importance of regular protection. (2003) (58)
Trends in dermatology: melanoma incidence. (2010) (57)
Predicting recurrence of basal-cell carcinomas treated by microscopically controlled excision: a recurrence index score. (1981) (57)
The rationale of the ABCDs of early melanoma. (1993) (57)
Prognostic index for malignant melanoma. (1978) (56)
Metastases of thin melanomas (1983) (55)
Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. (2008) (55)
Squamous-cell carcinoma treated by Mohs' surgery: an experience with 414 cases in a period of 15 years. (1981) (55)
Relationship of nevocytic nevi to sun exposure in dysplastic nevus syndrome. (1985) (53)
Mohs surgery for periocular basal cell carcinomas. (1985) (52)
Epidemiology and prognostic factors in malignant melanoma. (1992) (52)
The clinical features of malignant melanoma. (1985) (51)
Analysis of Trends in Geographic Distribution of US Dermatology Workforce Density (2017) (50)
Influence of gender on survival in patients with stage I malignant melanoma. (1992) (49)
Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists. (2005) (47)
The effect of sunscreen on melanoma risk. (2002) (46)
Identification of high‐risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31‐gene expression profile–based classification (2017) (46)
Congenital-nevus-like nevi, nevi spili, and café-au-lait spots in patients with malignant melanoma. (1985) (45)
Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis. (1983) (44)
Sun Protection by Beach Umbrella vs Sunscreen With a High Sun Protection Factor: A Randomized Clinical Trial (2017) (44)
Occupation and the risk of malignant melanoma (1995) (43)
Volume of malignant melanoma is superior to thickness as a prognostic indicator. Preliminary observation. (1991) (43)
SPF 100+ sunscreen is more protective against sunburn than SPF 50+ in actual use: Results of a randomized, double‐blind, split‐face, natural sunlight exposure clinical trial (2017) (42)
Impact of guidance from a computer-aided multispectral digital skin lesion analysis device on decision to biopsy lesions clinically suggestive of melanoma. (2012) (42)
Factors influencing survival in melanoma. (1991) (42)
The immediate impact of COVID-19 on US dermatology practices (2020) (41)
Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical‐mole syndrome: a case‐control study (1996) (41)
RISK GRADIENT FOR MALIGNANT MELANOMA IN INDIVIDUALS WITH DYSPLASTIC NAEVI (1988) (39)
Hazard-rate analysis in state I malignant melanoma. (1986) (38)
Relationship of fluorescent lights to malignant melanoma: another view. (1983) (37)
Clinical Diagnosis of Skin Cancer: Enhancing Inspection and Early Recognition. (2017) (37)
The dysplastic nevus. Clinical and pathologic features. (1985) (37)
What's New in Melanoma. (2019) (37)
Dysplastic nevi (1989) (36)
Validation of a 40-Gene Expression Profile Test to Predict Metastatic Risk in Localized High-Risk Cutaneous Squamous Cell Carcinoma. (2020) (36)
Computer applications in the diagnosis and prognosis of malignant melanoma. (1991) (36)
Acanthosis Nigricans and the sign of leser‐trélat associated with adenocarcinoma of the gallbladder (1981) (34)
An Estimate of the Incidence of Malignant Melanoma in the United States: Based on a Survey of Members of the American Academy Of Dermatology (1995) (33)
Occupation and the risk of malignant melanoma. (1995) (33)
Level of education and the risk of malignant melanoma. (1992) (32)
Relationship of lumbosacral nevocytic nevi to sun exposure in dysplastic nevus syndrome. (1986) (32)
A comparison of sunburn protection of high-sun protection factor (SPF) sunscreens: SPF 85 sunscreen is significantly more protective than SPF 50. (2010) (31)
Management of cutaneous malignant melanoma by dermatologists of the American Academy of Dermatology. I. Survey of biopsy practices of pigmented lesions suspected as melanoma. (1995) (31)
The effect of sunscreen on melanoma risk. (2002) (31)
Trends in dermatology: geographic density of US dermatologists. (2010) (30)
The relationship between melanocytic nevi and malignant melanoma. (1988) (30)
The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers (2021) (30)
Risk factors for the development of primary cutaneous melanoma. (2012) (30)
Sun-protection behaviors used by adults for their children--United States, 1997. (1998) (29)
Long-term Follow up of Diclofenac Sodium 3% in 2.5% Hyaluronic Acid Gel for Actinic Keratosis: One-year Evaluation. (2009) (29)
Influence of anatomic location on prognosis of malignant melanoma: attempt to verify the BANS model. (1986) (28)
Correlation of thicknesses of superficial spreading malignant melanomas and ages of patients. (1981) (28)
Metastases of thin melanomas. (1983) (28)
Precursors of malignant melanoma. Problems in computing the risk of malignant melanoma arising in dysplastic and congenital nevocytic nevi. (1985) (27)
Commentary: A responsible approach to maintaining adequate serum vitamin D levels. (2007) (25)
Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists' Clinical Management Decisions. (2017) (25)
Management of cutaneous malignant melanoma by dermatologists of the American Academy of Dermatology. II. Definitive surgery for malignant melanoma. (1995) (25)
Cigarette smoking and malignant melanoma. Prognostic implications. (1981) (23)
Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report. (2008) (23)
Assessment of clinician accuracy for diagnosing melanoma on the basis of electrical impedance spectroscopy score plus morphology versus lesion morphology alone (2019) (23)
Understanding efficacy end‐points in studies of field‐directed therapy for actinic keratosis (2013) (22)
Management of dysplastic nevi: A 14-year follow-up survey assessing practice trends among US dermatologists. (2015) (21)
MALIGNANT MELANOMA AND EXPOSURE TO FLUORESCENT LIGHTING AT WORK (1983) (19)
Photoprotection: a 21st century perspective (2002) (19)
Epiluminescence microscopy in clinical diagnosis of pigmented skin lesions? (1997) (18)
A comparison of current practice patterns of US dermatologists versus published guidelines for the biopsy, initial management, and follow up of patients with primary cutaneous melanoma. (2016) (18)
Scientific and regulatory issues related to indoor tanning. (2004) (18)
Distinguishing benign and malignant melanocytic lesions with the AgNOR method. (1991) (17)
Prognosis of malignant melanoma. (1985) (17)
Natural advances in eczema care. (2007) (17)
Daily UVB exposure levels in high-school students measured with digital dosimeters. (2003) (16)
Risk of developing cutaneous malignant melanoma in atypical-mole syndrome: New York University experience and literature review. (1995) (16)
Actinic Keratosis: Current Therapies and Insights Into New Treatments (2019) (16)
Skin types in dysplastic nevus syndrome. (1988) (16)
Is the ounce of screening and prevention for skin cancer worth the pound of cure? (1998) (16)
Factors Related to Thickness of Melanoma (1981) (15)
"Small" melanomas: relation of prognostic variables to diameter of primary superficial spreading melanomas. (1982) (15)
Impact of Guidance Provided by a Multispectral Digital Skin Lesion Analysis Device Following Dermoscopy on Decisions to Biopsy Atypical Melanocytic Lesions. (2015) (15)
The ABCDs of melanoma: why change? (1995) (15)
Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month follow-up of negative test results and utility data from a large US registry study. (2019) (15)
Photographs are useful for detection of malignant melanomas in patients who have dysplastic nevi (1988) (15)
Dermatologists’ Perceptions, Recommendations, and Use of Sunscreen (2017) (14)
What is the evidence for a sunscreen and melanoma controversy? (2000) (14)
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. (1982) (14)
Non-Invasive Gene Expression Testing to Rule Out Melanoma. (2018) (13)
Negative predictive value of pigmented lesion evaluation by multispectral digital skin lesion analysis in a community practice setting. (2015) (12)
Trends in US sunscreen formulations: Impact of increasing spray usage (2018) (12)
Innovations in natural antioxidants and their role in dermatology. (2008) (12)
The Impact of Quantitative Data Provided by a Multi-spectral Digital Skin Lesion Analysis Device on Dermatologists'Decisions to Biopsy Pigmented Lesions. (2017) (12)
The management of patients with dysplastic and congenital nevi. (1985) (11)
The Impact of Multispectral Digital Skin Lesion Analysis on German Dermatologist Decisions to Biopsy Atypical Pigmented Lesions with Clinical Characteristics of Melanoma. (2015) (11)
Analysis of US dermatology physician assistant density (2017) (11)
Assessment of a Diagnostic Predictive Probability Model Provided by a Multispectral Digital Skin Lesion Analysis Device for Melanoma and Other High-risk Pigmented Lesions and its Impact on Biopsy Decisions. (2014) (11)
A Systematic Review and Meta-Analysis of Gene Expression Profiling for Primary Cutaneous Melanoma Prognosis (2020) (10)
The continuing impact of COVID-19 on dermatology practice: Office workflow, economics, and future implications (2020) (10)
DERM/INFONET: a concept becomes a reality. (1988) (10)
Melanoma incidence: if it quacks like a duck... (1997) (10)
Enhancement of International Dermatologists' Pigmented Skin Lesion Biopsy Decisions Following Dermoscopy with Subsequent Integration of Multispectral Digital Skin Lesion Analysis. (2016) (10)
Online Survey of US Dermatologists' Sunscreen Opinions: Perceptions, Recommendation Factors, and Self-Usage. (2016) (9)
Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment (2019) (9)
Polypodium leucotomos extract: a status report on clinical efficacy and safety. (2015) (9)
Factors Affecting Dermatologists' Use of a 31-Gene Expression Profiling Test as an Adjunct for Predicting Metastatic Risk in Cutaneous Melanoma. (2018) (9)
Assessing frequency and quality of US dermatologist sunscreen recommendations to their patients. (2015) (9)
Sun-protection behaviors used by adults for their children - United States, 1997 (1998) (9)
Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma (2020) (9)
Integrating Skin Cancer-Related Technologies into Clinical Practice. (2017) (9)
The Importance of Early Recognition of Skin Cancer. (2017) (8)
PHOTOPROTECTION FOR ALL: CURRENT GAPS AND OPPORTUNITIES (2021) (8)
Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists (2019) (8)
Is it time for a computer in your practice? II. What tasks your computer can perform. (1982) (7)
Is it time for a computer in your practice? V. How to evaluate if a computer is appropriate for your practice. (1985) (7)
Patient knowledge of FDA‐mandated sunscreen labeling terminology: A cross‐sectional survey (2018) (7)
Tanning bed hygiene: microbes found on tanning beds present a potential health risk. (2010) (7)
Frequency of total body skin examinations among US dermatologists (2017) (7)
Online sunscreen purchases: Impact of product characteristics and marketing claims (2019) (7)
The gender-related issues in malignant melanoma. (1993) (7)
Oxybenzone and Sunscreens: A Critical Review of the Evidence and a Plan for Discussion with Patients (2018) (7)
Is it time for a computer in your practice? I. Introduction. (1981) (7)
Medical office computer systems. The selection process. (1986) (6)
Assessing Genetic Expression Profiles in Melanoma Prognosis. (2017) (6)
Corrigendum: Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month followup of negative test results and utility data from a large US registry study. (2019) (6)
Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test (2018) (5)
Pigmented Skin Lesion Biopsies After Computer-Aided Multispectral Digital Skin Lesion Analysis (2015) (5)
Dermatologist Practices During Total Body Skin Examinations: A Survey Study. (2018) (5)
Gaps in the understanding and treatment of skin cancer in people of color. (2016) (5)
Realistic Sunscreen Durability: A Randomized, Double-blinded, Controlled Clinical Study. (2018) (5)
Impact of Electrical Impedance Spectroscopy on Dermatologists' Number-Needed-to-Biopsy Metric and Biopsy Decisions for Pigmented Skin Lesions. (2020) (5)
Correlation Between the Evaluation of Pigmented Lesions by a Multi-spectral Digital Skin Lesion Analysis Device and the Clinical and Histological Features of Melanoma. (2016) (5)
Noninvasive Technologies for the Diagnosis of Cutaneous Melanoma. (2017) (5)
Enhanced melanoma diagnosis with multispectral digital skin lesion analysis. (2018) (4)
Commentary: The incidence of nonmelanoma skin cancer: can we make an impact? (2014) (4)
Increasing Diversity in Dermatology Residencies. (2017) (4)
Identification of those at highest risk for development of malignant melanoma. (1995) (4)
Clinical efficacy & safety of oral Polypodium leucotomos extract for photoprotection: A systematic review (2018) (4)
Shedding light on complete UV protection (2006) (4)
Electrical Impedance Spectroscopy Versus Clinical Inspection Approaches: Melanoma Efficacy Detection Comparison (2018) (4)
The frequency of self-skin examination and full body skin examination in dermatologists. (2011) (3)
Hat-wearing patterns in spectators attending baseball games: a 10-year retrospective comparison. (2016) (3)
The Importance of Early Detection of Melanoma, Physician and Self-Examination (2011) (3)
Factors related to thickness of melanoma. Multifactorial analysis off variables correlated with thickness of superficial spreading malignant melanoma in man. (1981) (3)
Quantitative ABCD parameters measured by a multispectral digital skin lesion analysis device for evaluation of suspicious pigmented skin lesions strongly correlate with clinical ABCD observations. (2017) (3)
A Multivariate Analysis of Prognostic Factors for Melanoma Patients with Lesions > 3.65 mm in Thickness The Importance of Revealing Alternative Cox Models* (1982) (3)
Cancer of the Skin. (2011) (3)
Assessment of the 31-Gene Expression Profile Test by Dermatologists: A Cross-Sectional Survey from National Dermatology Conferences (2021) (3)
Integrating Electrical Impedance Spectroscopy into Clinical Decisions for Pigmented Skin Lesions Improves Diagnostic Accuracy: A Multitiered Study (2020) (3)
Melanoma Reporting Practices of United States Dermatologists (2018) (3)
A Phase IV, Open-label assessment of the treatment of actinic keratoses with diclofenac sodium 3% topical gel1 (2004) (3)
High sun-protection factor sunscreens (≥70) may provide ultraviolet protection above minimal recommended levels by adequately compensating for lower sunscreen user application amounts. (2013) (3)
Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working Group (2022) (3)
Treatment of non-melanoma skin cancer: immunotherapy as a viable option. (2003) (3)
Introduction: immunotherapy for dermatological conditions. (2003) (3)
Comparison of the Distribution of Morphological Disorganization of Pigmented Lesions in a Community-based Practice versus a University-based Clinical Setting as Measured by a Multispectral Digital Skin Lesion Analysis Device: Impact on Diagnosis. (2015) (2)
Ultraviolet index counseling as a primary prevention strategy by US dermatologists (2020) (2)
Deaths related to liposuction. (1999) (2)
Is it time for a computer in your practice? III: Types of computer systems for medical offices. (1982) (2)
Gene Expression Profile Testing in Skin Cancer Prognosis: The Data is Clear – It’s Time to Get On Board (2020) (2)
A Phase IV, Open-label assessment of the treatment of actinic keratoses with diclofenac sodium 3% topical gel 1 1 All Authors have served as investigators on this study, have research support and have acted as consultants for Bioglan. (2004) (2)
Editorial: Overcoming Consumer Challenges in Sunscreen Selection (2018) (2)
Cutaneous malignant melanomas, five-year survival. (1982) (2)
Cutaneous Implications of Whole Body Cryotherapy (2017) (2)
Skin cancer: in your face (1999) (2)
Non-Invasive Technologies for the Diagnosis and Management of Skin Cancer (2017) (2)
Discussion: research update on external genital warts and other viral dermatoses (2003) (2)
Comparison of Survey Modality and Response Rate in Dermatologists’ Perceptions and Opinions of Sunscreens (2018) (2)
Lack of selective attendance of participants at skin cancer/melanoma screening clinics. (1994) (2)
Photoprotection and the Prevention of Photocarcinogenesis (2005) (2)
Response to CME article "Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions. Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology". (2015) (2)
Current Concepts in Photoprotection (2011) (1)
Passing a small-bore nasogastric feeding catheter. (1980) (1)
Integrating electrical impedance score into decision to biopsy increases biopsy efficiency (2019) (1)
Lesion thickness and prognosis in melanoma: horses are not zebras. A response to Green and Ackerman. (1993) (1)
Expert Consensus on Sunscreen for the Primary Prevention of Skin Cancer: Results of the Skin Cancer Prevention Working Group Conference (2021) (1)
The Importance of Recognition of the Skin Cancer Risk of Native Americans: A Call to Action (2017) (1)
Improvement of risk assessment in cutaneous melanoma (CM) by a prognostic 31-gene expression profile (31-GEP) test over AJCC-based staging alone (2018) (1)
Furuncular Cutaneous Myiasis (1)
The future of computers in dermatology. (1986) (1)
Risk of Cutaneous Malignant Melanoma in Patients WithClassic' Atypical-Mole Syndrome (2016) (1)
Analysis of Dermatologic Disorders Occurring in Major League Baseball Players (2017) (1)
The Rate of Malignant Melanoma in the United States: Are We Making an Impact (1988) (1)
Successful Treatment of Generalized Essential Telangiectasia With 6-Mercaptopurine. (2017) (1)
The dilemma of the dysplastic nevus. (1992) (1)
Surgical gem. modification of surgical gloves to prevent exposure to hepatitis during hair transplantation surgery. (1983) (1)
Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report. (2021) (1)
Evaluating Industry Payments Among Dermatology Clinical Practice Guideline Authors. (2018) (1)
Is Absorption of Sunscreen Truly a Problem? A Careful Review Suggests it is Not. (2019) (1)
Skin Self-examination for Skin Cancer Prevention. (2018) (1)
Physician management differs regarding skin cancer for white compared with nonwhite patients (2018) (1)
Learn about non-ablative skin rejuvenation techniques using intense pulsed light, including conventional and photodynamic skin rejuvenation. (2003) (1)
Melanoma and pigmented lesions (2002) (1)
Book Review Textbook of Melanoma Edited by John F. Thompson, Donald L. Morton, and Bin B.R. Kroon. 687 pp., illustrated. New York, Martin Dunitz, 2004. $309.95. 1-90186-565-7 (2004) (1)
Is it time for a computer in your practice? IV. Which practices benefit? (1983) (1)
Usage and perceptions of teledermatology in 2021: a survey of dermatologists (2022) (1)
Cancer of the Skin, 2nd Edition (2011) (1)
Integrating Genomic Testing for Melanoma Into Your Practice (2022) (1)
THE ABCDS OF MELANOMA : WHY CHANGE ? AUTHOR'S REPLY (1995) (1)
Factors Influencing Dermatology Rank List Preferences Among Successful Applicants (2019) (0)
Passing of Robert J. Friedman, MD MSc. (2021) (0)
Photorejuvenation Non-Ablative Skin Rejuvenation Using Intense Pulsed Light (2001) (0)
The Magnitude of Increased US Melanoma Incidence Attributable to Ground-Level Ultraviolet Radiation Intensity Trends. (2020) (0)
How Insurers Attempt to Discourage Biologic Therapy for Psoriasis (2013) (0)
Characteristic Distinctions Between Pre-/Post-COVID-19 Teledermatology Adoptees: A Cross-Sectional United States-based Analysis and the Implications for Dermatologic Healthcare Equity. (2022) (0)
Development of a Photonumeric Lip Health Scale. (2020) (0)
Passing of Robert J. Friedman, MD MSc. (2021) (0)
An Expert Panel Questionnaire for Assessing Patient-Reported and Clinician-Reported Outcomes in Actinic Keratosis (2022) (0)
Pathobiology and recognition of malignant melanoma, Martin C. Mihm, George F. Murphy, Nathan Kaufman. Williams & Wilkins, Baltimore (1988), 180 pages. $49.50 (1989) (0)
31-Gene Expression Profile Assessing Metastatic Risk in Melanoma Patients: Issues Impacting Patient Selection (2017) (0)
Sun Protection and Self‐Tanners (2013) (0)
EVIDENCE SYNTHESIS Genesis , Validation , and Critique of the ABCDs In (2004) (0)
Comparing Electrical Impedance Spectroscopy to Traditional Clinical Adjunctive Tools in the Detection of Melanoma (2017) (0)
Differential Impact of COVID-19 on Urban Versus Rural Dermatologic Practice Logistics and Recovery: A Cross-Sectional Investigation of the First Wave (2021) (0)
Sunscreen: Prevention of Aging and Skin Cancer (1995) (0)
Pilot Study Assessing the Efficacy of a Novel Topical Adhesive for Dermatologic Excisional Wound Closure (2017) (0)
Benign Pigmented Lesions (2006) (0)
The Magnitude of Increased US Melanoma Incidence Attributable to Ground-Level Ultraviolet Radiation Intensity Trends: Supplemental Data (2020) (0)
The ABCDs of moles and melanomas (2007) (0)
14087 Integrating genomics for the diagnosis and prognosis of melanoma into clinical practice (2020) (0)
The Low Prevalence of Allergic Contact Dermatitis Using a Petrolatum Ointment Containing Lanolin Alcohol (2019) (0)
The Impact of the COVID-19 Pandemic on Physician-Pharmaceutical Office-Based Interactions. (2021) (0)
The Integrated 31-Gene Expression Profile (i31-GEP) Test for Cutaneous Melanoma Outperforms a Clinicopathologic-only Nomogram at Identifying Patients who can Forego Sentinel Lymph Node Biopsy (2022) (0)
Melanoma and pigmented lesions. Introduction. (2002) (0)
Skin Cancer Screenings: Why Are the Benefits in Question? (2022) (0)
Wysong et al. JAAD 2020. Supplemental Methods and Data. Validation of a 40-Gene Expression Profile Test to Predict Metastatic Risk in Localized High-Risk Cutaneous Squamous Cell Carcinoma (2020) (0)
Highlights of the American Academy of Dermatology 61 st Annual Meeting (2006) (0)
Comprar Cancer of the Skin, 2nd Edition | Leonard M. Dzubow | 9781437717884 | Saunders (2011) (0)
Precursor lesions and melanoma: 008 (1997) (0)
Using Genomics to Improve Pigmented Lesion Management & Health Outcomes (2022) (0)
Preference Signaling in the Dermatology Residency Match (2022) (0)
13541 Integrating data from an electrical impedance spectroscopy device improves pigmented lesion diagnostic accuracy among dermatology mid-level providers (2020) (0)
Patient-Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis in Real-world Settings: PROAK Study Protocol (2022) (0)
Is the Unsuit unsuitable? (1984) (0)
Electrical impedance spectroscopy significantly enhances correct biopsy choice for pigmented skin lesions beyond clinical evaluation and dermoscopy (2022) (0)
Variance from published guidelines and changes in temporal trends in the management of cutaneous malignant melanoma: a 5-year update (2022) (0)
The Continuing Impact of COVID-19 on Dermatology Practice: Office Workflow, Economics and Future Implications: Supplemental Data (2020) (0)
Recurrence prediction in cutaneous melanoma with 31-gene expression profiling and sentinel lymph node biopsy (2019) (0)
Multimedia: Skin cancer: in your face (1999) (0)
Evaluating the Utility of Self and Clinical Skin Examinations to Screen for Skin Cancer: The Importance of Considering Publications of All Levels of Evidence (2018) (0)
Supplemental Figure & Tables (2020) (0)
Erythrasma Under Wood's Lamp and the Coral Red Glow (2022) (0)
Considerations in the Management of Actinic Keratoses: The Importance of Adherence and Persistence to Therapy (2021) (0)
Current and developing techniques to diagnose melanoma. (2012) (0)
The Ongoing Impact of COVID-19 on US Dermatology Practices (2021) (0)
Vitamin D and UV (2011) (0)
Newer and Emerging Therapies for Dermatologic Diseases and Conditions (2015) (0)
Impact of Actinic Keratosis (AK), as measured by patient-reported AK symptoms, and impact on emotions and functioning (using Skindex-16) among patients with AK administered tirbanibulin in real-world community practices across the U.S. (PROAK Study) (2023) (0)
Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging (2022) (0)
15871 A demonstration of the excellent tolerability and safety of a lanolin alcohol–containing wound healing ointment (2020) (0)
Clinical Experience with a Novel Topical Adhesive for Dermatologic Excisional Wound Closure: A Case-Series (2018) (0)
Incorrect P Value in Table 3. (2017) (0)
The Many Faces of Melanoma (2011) (0)
Factors affecting dermatologists’ decision to use a 31-gene expression profiling test to assess metastatic risk for melanoma patients (2018) (0)
The Impact of the COVID-19 Pandemic on Physician-Pharmaceutical Office-Based Interactions (2021) (0)
Health Econommic Implications of a Non-Invasive Gene Expression Test for Primary Cutaneous Melanoma (2017) (0)
Erratum to “Melanoma and pigmented lesions” [Dermatol Clin 20 (2002) xv] (2003) (0)
Discussion: mode of action of imiquimod (2003) (0)
Types of Shade Vary in Protection Just Like Sunscreens-Reply. (2017) (0)
Natural approaches to management of photoaging. (2008) (0)
Toward optimal health: the experts respond to skin cancer. Interview by Jodi Godfrey Meisler, M.S., R.D.. (1999) (0)
Ulcerations and Lymphadenopathy in a 42 year old Male (2022) (0)
Computing for Clinicians (1989) (0)
Computers in dermatology. Review of communication software for dermatology. (1987) (0)
The American Academy of Dermatology: Challenges and Opportunities as We Approach the New Century (1999) (0)
Knowledge Gaps Among Dermatologists Regarding Immunotherapy for Non-melanoma Skin Cancer. (2022) (0)
Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study) (2023) (0)
Dermatology Match Preference Signaling Tokens: Impact and Implications (2022) (0)
Systemic Implications of Melanoma (2021) (0)
Hypopigmented Patches on the Trunk of a 25-year-old Hispanic Male (2022) (0)
In Consideration of the E in the Melanoma ABCDE Mnemonic—Reply (2006) (0)
Computers in Dermatology (1988) (0)
Management of dysplastic nevi: a 6 year follow-up survey assessing practice trends among US dermatologists. (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Darrell S. Rigel?

Darrell S. Rigel is affiliated with the following schools:

Darrell S. Rigel's Academic­Influence.com Rankings

Darrell S. Rigel's Degrees

Why Is Darrell S. Rigel Influential?

Darrell S. Rigel's Published Works

Published Works

What Schools Are Affiliated With Darrell S. Rigel?

Darrell S. Rigel's AcademicInfluence.com Rankings